A total of 81 institutions have reported a stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| 5AM Venture Management, LLC | 31 Dec, 2025 | 3,947,913 | 3,457,913 | 705.70% | $5,329,683.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 2,883,745 | 558,390 | 24.01% | $3,893,056.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,855,590 | -48,810 | -1.68% | $3,855,047.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 2,849,294 | 4,142 | 0.15% | $3,839.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 1,964,255 | -113,035 | -5.44% | $2,651,744.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 1,660,378 | 251,575 | 17.86% | $2,241,510.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 1,483,500 | 22,300 | 1.53% | $2,002,725.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,471,414 | 108,067 | 7.93% | $1,986,409.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 1,400,906 | 1,084,356 | 342.55% | $1,891,223.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 1,367,254 | -181,527 | -11.72% | $1,845,793.00 |
| Decheng Capital LLC | 31 Dec, 2025 | 1,323,327 | 0 | 0.00% | $1,786,491.00 |
| Ishara Investments LP | 31 Dec, 2025 | 1,320,000 | 1,320,000 | 0.00% | $1,782,000.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,249,968 | 464 | 0.04% | $1,687,457.00 |
| GSA CAPITAL PARTNERS LLP | 31 Dec, 2025 | 1,169,573 | 91,917 | 8.53% | $1,579.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 31 Dec, 2025 | 957,420 | -5,200 | -0.54% | $1,292,517.00 |
| PFIZER INC | 31 Dec, 2025 | 953,834 | 0 | 0.00% | $1,287,675.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 803,654 | -604,175 | -42.92% | $1,084,932.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Dec, 2025 | 787,055 | 406,233 | 106.67% | $1,062,524.00 |
| UBS Group AG | 31 Dec, 2025 | 674,598 | 141,920 | 26.64% | $910,707.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 673,129 | -229,392 | -25.42% | $908,724.00 |